IRF4 Gene Expression Associated With Development of Acute Myeloid Leukemia, Myelodysplastic Syndrome
Researchers sought to determine whether IRF4 expression is associated with an increased susceptibility to de novo AML and myelodysplastic syndrome.
Myelodysplastic Syndromes
Immune Checkpoint Inhibitor Combination Therapy Promising for AML, MDS
Researchers reviewed the challenges and future developments in ICI combination therapies for the treatment of patients with acute myeloid leukemia and myelodysplastic syndromes.
Myelodysplastic Syndromes: Gene Expression Signatures May Predict Response to Azacitidine
Among some patients with myelodysplastic syndrome, gene expression signatures appear to be predictive of response and primary resistance to azacitidine.
- Loading...
Loading...
Next post in Side-Effect Management
Loading... 
Loading...